| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |